Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Marini

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Thrombosis and Haemostasis|November 28, 2022
Characterization of Shear Stress Mediated Platelet Dysfunction: Data from an Ex Vivo Model for Extracorporeal Circulation and a Prospective Clinical StudyOleg Hidiatov, Alisha Gaupp, Irene Marini, et al.
Haematologica|March 30, 2019
Glycoprotein V is a relevant immune target in patients with immune thrombocytopeniaRichard Vollenberg, Rabie Jouni, Peter A A Norris, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2020
Dosimetry and safety of <sup>177</sup>Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patientsGiovanni Paganelli, Anna Sarnelli, Stefano Severi, et al.
Frontiers in Medicine|February 9, 2026
Radioligand therapy for primary brain tumors: a PRISMA-based systematic review of meningiomas and gliomasIlaria Grassi, Maddalena Sansovini, Federica Matteucci, et al.
Blood|January 29, 2021
Antibody-induced procoagulant platelets in severe COVID-19 infectionKarina Althaus, Irene Marini, Jan Zlamal, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 29, 2024
Correlation of [<sup>68</sup>Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patientsEmilio Francesco Giunta, Paola Caroli, Emanuela Scarpi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 27, 2025
Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II studyIrene Marini, Emilio Francesco Giunta, Silvia Nicolini, et al.
Scientific Reports|February 5, 2020
Beta-Glycerophosphate-Induced ORAI1 Expression and Store Operated Ca<sup>2+</sup> Entry in MegakaryocytesLisann Pelzl, Itishri Sahu, Ke Ma, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 14, 2024
Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-upStefano Severi, Ilaria Grassi, Alberto Bongiovanni, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Thrombosis and Haemostasis|November 28, 2022
Characterization of Shear Stress Mediated Platelet Dysfunction: Data from an Ex Vivo Model for Extracorporeal Circulation and a Prospective Clinical StudyOleg Hidiatov, Alisha Gaupp, Irene Marini, et al.
Haematologica|March 30, 2019
Glycoprotein V is a relevant immune target in patients with immune thrombocytopeniaRichard Vollenberg, Rabie Jouni, Peter A A Norris, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2020
Dosimetry and safety of <sup>177</sup>Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patientsGiovanni Paganelli, Anna Sarnelli, Stefano Severi, et al.
Frontiers in Medicine|February 9, 2026
Radioligand therapy for primary brain tumors: a PRISMA-based systematic review of meningiomas and gliomasIlaria Grassi, Maddalena Sansovini, Federica Matteucci, et al.
Blood|January 29, 2021
Antibody-induced procoagulant platelets in severe COVID-19 infectionKarina Althaus, Irene Marini, Jan Zlamal, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 29, 2024
Correlation of [<sup>68</sup>Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patientsEmilio Francesco Giunta, Paola Caroli, Emanuela Scarpi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 27, 2025
Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II studyIrene Marini, Emilio Francesco Giunta, Silvia Nicolini, et al.
Scientific Reports|February 5, 2020
Beta-Glycerophosphate-Induced ORAI1 Expression and Store Operated Ca<sup>2+</sup> Entry in MegakaryocytesLisann Pelzl, Itishri Sahu, Ke Ma, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 14, 2024
Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-upStefano Severi, Ilaria Grassi, Alberto Bongiovanni, et al.
Pageof 3